The FLOW trial was conducted over a long period, meaning that care has evolved since the trial was started
2 Starting or switching patients to once-daily Tresiba With a 1:1 dose conversion, adult patients treated with a long-acting basal insulin can switch to Tresiba at the same dose they are currently taking
Some of the DPP-4 inhibitors are substrates of DPP-4 whereas others bind to the catalytic site without being degraded
The FDA does not review these medications for safety or efficacy
Curr J Neurol 22(1):3034 Hauschild TC, Guerreiro G, Mescka CP, Coelho DM, Steffens L, Moura DJ, Manfredini V, Vargas CR (2019) DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine
In functional medicine, our goal is to restore optimal and balanced immune function